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Abstract: 
Background and purpose: Complementary and alternative medicine (CAM) therapies are commonly used by cancer 
patients around the world. The aim of this cross-sectional study was to explore the extent of CAM therapies use by 
cancer patients, discover patients’ motives, sources, and beliefs regarding the benefits of CAM therapies, and 
determine patient awareness of possible adverse effects.  
Materials and methods: A comprehensive, validated questionnaire in Arabic was explained and given to patients 
who provided their consent to participate. All patients attended King Saud University-Medical City Oncology 
Center.  
Results: Among the patients, 136  responded to the questionnaire and 97 (71.3%) reported using some form of CAM 
therapies. The most frequently used CAM therapies were Zamzam water (Holy water from Makkah), honey, olive 
oil, black seeds, dates, and camel milk (with/without camel urine). Many patients were unaware of any adverse 
effects of CAM therapies. Statistical analyses showed that there were no significant differences between users and 
non-users in terms of gender, age, nationality, marital status, or educational level (p<.05). 
Conclusion: Many cancer patients use various forms of CAM therapies because they believe that CAM therapies 
may be beneficial and are harmless. 
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INTRODUCTION: 
Cancer is a worldwide health problem. It is one of the 
leading causes of death. 8.2 million people die each 
year from cancer, an estimated 13% of all deaths 
worldwide. 70% increase in new cases of cancer 
expected over the next 2 decades [1]. 
Previous studies have shown that many cancer 
patients use CAM therapies worldwide both in under-
developed countries and developed areas such as 
Europe, India, and the Arab countries [2-6]. 
 
Complementary/alternative medicine (CAM) can be 
defined as “a group of diverse medical and health 
care systems, practices, and products that are not 
presently considered to be part of conventional 
medicine” [7], they vary from one society to another 
[8]. 
Patients with cancer often believe that they will 
eventually die from the disease, despite the 
availability of effective therapies; therefore, they tend 
to try anything that could be of benefit, and they seek 
hope through CAM therapies. One of the reasons 
patients use CAM therapies is because they obtain 
information about their disease and receive advice 
from not only their physicians but also equally from 
their communities and the internet [9-10]. 
Some patients believe that CAM therapies can 
effectively cure cancer or alleviate the adverse effects 
of chemotherapy and radiotherapy without producing 
adverse effects [10-11]. We opted to study CAM 
therapies because it is widely used and accepted by 
our society. 
The aim of this study is to uncover several aspects of 
CAM therapies use among cancer patients at King 
Saud University-Medical City Oncology Center. We 
want to estimate the magnitude of using 
complementary/alternative medicine (CAM) 
therapies in cancer patients at KSUMC, determine 
types of CAM therapies and frequency of using, 
sources of information about CAM therapies, and 
figure out patients’ beliefs about using CAM 
therapies. 
 
MATERIAL AND METHODS:  
This cross-sectional study was conducted among 
cancer patients at King Saud University-Medical City 
Oncology Center, Riyadh from September 2015 to 
April 2016. The sample size was calculated as 138 
patients from a standard equation, Z2 α P(1-P)/d2 = 
1.962 x .9 x (1-.9) / .052 = 138.3 While Zα = 1.96 , P 
is Proportion and d is precision. Proportion was taken 
from a previous research about patterns of CAM 
therapies in Riyadh. The inclusion criteria were as 
follows: male and female adult patients (18 years old 
and over), attendance at the oncology department for 
different types of cancer, Saudi and non-Saudi 
nationalities, and receiving and not receiving medical 
treatment. We excluded patients who did not know 
about their cancer diagnosis and those who did not 
respond. A convenience sampling method was used, 
which meant that the questionnaire was distributed 
among available patients without randomization. A 
pilot study was performed on 13 participants to test 
the questionnaire. Data were collected from the 
completed questionnaires and interviews were 
provided for patients who could not read or write. 
The study objectives and the significance of the 
questionnaire were explained in the introduction and 
all participants provided informed consent. 
The questionnaire was divided into three variable 
sections: 
 
1- Demographic data: gender, age, nationality, 
education, and income. 
 2- Disease characteristics: information about the 
patient’s cancer and any chronic diseases.  
 3- Complementary/alternative medicine: types of 
CAM therapies used, reasons for its use or non-use, 
sources, and the patient’s beliefs about CAM 
therapies. 
Data were entered into and analyzed by the Statistical 
Package for the Social Sciences (SPSS) for personal 
computers, version 21.0, and analyses with p < 0.05 
were considered significant. The chi-square test was 
used to determine whether there were significant 
associations between the categorical variables.      
  
RESULTS:  
We included 136 patients out of 138 (98.6%), we 
excluded 2 questionnaires due to lots of missing data. 
The demographic data are shown in Table 1. Nearly 
two-thirds of the patients were women. Most of the 
patients were over 50 years old and married. Types of 
cancer included breast in 33.8% and colon in 23.5%. 
Chemotherapy was the main cancer treatment for 
93.1% of patients. The disease characteristics are 
shown in Table 2.  
 
 Of the 136 patients, 97 (71.3%) reported using CAM 
therapies, while 39 (28.7%) did not. The reasons 
given for not using CAM therapies were as follows: 
satisfaction with medical treatment (13 patients; 
34.2%), CAM therapies was deemed not beneficial 
(5; 13.2%), not aware of CAM therapies (15; 39.5%), 
warned against using it (1 patient; 2.6%), fear of side 
effects (9; 23.7%), afraid that it could interfere with 
conventional treatment (14; 36.8%), and other 
reasons (3; 7.9%). There were no statistically 
significant differences between the users and non-
users in terms of gender, age, nationality, marital 
status, or educational level (p<.05). The different 
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types of CAM therapies used and the frequency of 
their use are summarized in Table 3.  
 
The most common types of CAM therapies used 
were Zamzam water (89.7%) and honey (82.5%). 
The most common sources of information about 
CAM therapies were family (50.5%) and friends 
(43.3%). All sources are shown in Figure 1.  
 
Before using CAM therapies, 64 patients (68.8%) 
conducted their own research of the available 
information. The reasons given for using CAM 
therapies were to improve psychological/emotional 
well-being (44 patients; 45.8%), improve immunity 
(43; 44.8%), relieve the symptoms of cancer (35; 
36.5%), control the disease (26; 27.1%), relieve the 
side effects of medical treatment (21; 21.9%), 
succumbed to pressure from friends/family (13; 
13.5%), and other reasons such as CAM therapies 
being mentioned in the Qur’an and Sunnah, and 
because it is deemed harmless (21; 21.9%). Among 
the patients, 25 (26.3%) informed their physicians 
about their use of CAM therapies, while 70 (73.7%) 
did not. The reasons given for not informing the 
physicians were either the physician did not ask 
about CAM therapies use (45 patients; 63.4%), belief 
that CAM therapies is harmless (27; 38.0%), fear of 
being discouraged (7; 9.9%), forgot to mention it (2; 
2.8%), and various other reasons (6; 8.5%). We also 
asked the patients whether their physicians had asked 
about their use of CAM therapies and only 11 
patients (12.0%) reported that they had. CAM 
therapies use was reported to be of benefit by 67 
patients (69.1%). The most frequently reported 
benefit was psychological well-being, while other 
reasons included increased immunity and less severe 
disease symptoms. Only 8 patients (8.2%) reported 
that they had experienced adverse effects, which 
included infections and flank pain, from using CAM 
therapies. In addition, 25 (27.2%) patients thought 
that CAM therapies could cause adverse effects, 
while 67 (72.8%) thought that it had no adverse 
effects. 
 
DISCUSSION:  
The prevalenc of cancer patients use CAM therapies 
around the world including in European countries, 
United States, India, Korea, Singapore and Arab 
countries, and the proportion ranges from 15–100% 
[2-6, 12-20]. A European study indicated that 35.9% 
of cancer patients in Europe use CAM therapies [3]. 
A study was conducted in Munich, Germany, 15.2% 
used CAM therapies during their oncological 
treatment. More than one third of patients used it in 
the past [12]. In United States showed that most of 
cancer survivors used vitamins/minerals or at least 
one type of CAM therapies in the past year 78.8% 
[13]. Also, there was another study conducted in 
United States found 95.5% of participants used CAM 
therapies after 2 months of cancer adjuvant therapy 
[14]. A third study done in United States found the 
usage of CAM therapies was 61.3% [15]. 
In A study was done in Denmark, almost half of 
participants in the study (49.4%) used some CAM 
forms in the past month [16]. Also, a study conducted 
in Korea showed the prevalence in of 60.6% [17]. 
Another study conducted in southern Korea, 67% of 
participants, used CAM therapies [18]. The 
prevalence of CAM therapies use is 56% in 
Singapore and 34.3% in India [6, 19]. A Jordanian 
study showed that all cancer patients use CAM 
therapies (100%)[5]. In Saudi Arabia, a study 
conducted in Jeddah, the prevalence of CAM 
therapies use appeared to be only 21.6% [4], and 
other studies done in Riyadh showed rates of 69.9%, 
90.5% [20,21]. The relatively high prevalence of 
CAM therapies use is due to cultural and religious 
influences especially in eastern regions of the world. 
The most common type of CAM therapies used in 
our study was Zamzam water, which was followed by 
honey and Ruqya. Almost half of the patients used 
these types of CAM therapies daily. Herbs (turmeric, 
anise, and fenugreek), and camel milk with or 
without camel urine were used by a small percentage 
of the patients. In Denmark, respondents who 
consulted alternative practitioner, the most common 
therapies were massage, acupuncture, 
mindfulness/meditation, reflexology, and cranio-
sacral therapy [16] . Two studies conducted in 
Germany, found that most patients use selenium, 
supplements, and relaxation techniques [2,9]. While 
another study, food supplements, vitamins/minerals, 
massage, physiotherapy/manual medicine, 
homeopathy and herbs/plants were the most used 
types [12]. In a study done in Alabama, United States 
the most common CAM therapies used were prayer 
and multivitamins. Other CAM types were massage, 
music therapy, meditation, drinking green tea, 
chiropractic treatment [14].  Additional study showed 
that vitamins and minerals, herbal and non- vitamins 
supplements were the most common types [13]. 
  
 In Korea, most common types of CAM were 
exercise and yoga, ginseng, mushrooms, beans, 
multivitamins, prayer, meditation, and Zen [18]. 
While another study found that herbal medicine 
which includes red ginseng and mushroom, vitamins, 
acupuncture were the most used types [17]. 
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 In Jordan, the most frequently used types of CAM 
therapies were dietary and nutritional supplements 
including honey, olive oil, black seeds, and dates. In 
addition, a high percentage use Zamzam water and a 
quarter of the patients use herbs [5]. In Jeddah, more 
than half of the patients were reported to use herbs 
followed by Ruqya and Zamzam water [4], and in 
Riyadh, the most common types of CAM therapies 
used were religious like supplication, Quran 
recitation, Zamzam water, and reciting Quran over 
water. Among non-religious CAM therapies, olive oil 
was the most commonly used, followed by black 
seeds (Nigella sativa) [20].  
Previous studies have shown that patients use CAM 
therapies for various reasons, for example, to 
improve their immunity/general health 
[2,10,12,13,19], alleviate adverse effects and 
complications due to the disease or conventional 
chemotherapy/radiotherapy [5,12,18,19], and to take 
control of their disease [5,9,13,18]. In our study, the 
most common reasons for CAM therapies use were to 
improve psychological/emotional well-being, 
improve immunity, and relieve the symptoms of the 
disease. 
In our study, half of  the participants obtained 
information about CAM therapies from their families 
and friends. This is almost the same proportion as 
that found in the Jordanian study [5]. Physicians, 
nurses, and the internet have been found to be the 
most common sources of information about CAM 
therapies in Germany [9,12].  In Korea 40.4% and 
Denmark 66.1%, was their own decision to use CAM 
therapies [16,18].  When we compared our study to 
others, we found that the types of CAM therapies and 
sources of information used in Germany differed 
from ours, but the types of CAM therapies used were 
almost identical across the Muslim countries such as 
Jordan and Saudi Arabia [9,4,5].  
In a study, 53.7% discussed CAM therapies use with 
their oncologists or informed them about using it, 
while 46.3% did not [19]. In another one, more than 
half of participants didn’t tell their doctors about 
CAM therapies use [16]. 
The reasons for not informing the physicians were 
CAM therapies was considered harmless and not a 
medicine, the oncologist did not ask about it, and fear 
of being discouraged [18,19]. In our study, the most 
common reason for not informing the physician about 
CAM therapies use was the physician did not ask 
about it. 
 
The limitations of this study include the small sample 
size, which means we cannot generalize the findings 
for all patients with cancer who use CAM therapies. 
In addition, we used the convenience sampling 
method without randomization. The data on patients' 
beliefs were not reliable because the study was cross-
sectional and there was no follow-up period, hence, 
we could not determine whether the adverse effects 
were from CAM therapies or the medical treatments. 
Similarly, we could not determine whether the 
benefits were derived from CAM therapies or from 
additional medications taken as part of the 
treatments. 
 
CONCLUSION/RECOMMENDATIONS:  
The prevalence of CAM therapies use was high 
among cancer patients at KSUMC. Many patients 
believed that they obtained benefits from CAM 
therapies and that there are no adverse effects. We 
recommend that an analytical study should be 
conducted on patients using CAM therapies to gain 
an understanding of any possible benefits or adverse 
effects. 
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Table 1: Demographic data of the participants 
 
p value Chi square value Non user Users Number of patients (%) Variables 
0.544 0.368     Gender 
15 (31.9%) 32 (68.1%) 47 (34.6)    Male 
24 (27.0%) 65 (73.0%) 89 (65.4)    Female 
0.277 5.102    Age 
0 (0.0%) 4 (100.0%) 4 (2.9)    ≤ 20  
1 (25.0%) 3 (75.0%) 4 (2.9)    21-29 
5 (35.7%) 9 (64.3%) 14 (10.3)    30-39 
3 (13.6%) 19 (86.4%) 22 (16.2)    40-49 
30 (32.6%) 62 (67.4%) 92 (67.6)    ≥ 50  
0.678 0.172    Nationality 
26 (29.9%) 61 (70.1%) 87 (64.0)    Saudi 
13 (26.5%) 36 (73.5%) 49 (36.0)    Non Saudi 
0.840 0.839    Marital status 
3 (23.1%)
  
10 (76.9%) 13 (9.6)    Single 
31 (31.0%) 69 (69.0%) 100 (73.5)    Married 
2 (22.2%)
  
7 (77.8%)
  
9 (6.6)    Divorced 
3 (23.1%)
  
10 (76.9%) 13 (9.6)    Widow/ Widower 
  1 (.7)    No answer 
0.854 2.630    Educational level 
8 (26.7%)
  
22 (73.3%) 30 (22.1)    None 
1 (25.0%)
  
3 (75.0%)
  
4 (2.9)    Less than primary 
2 (15.4%)
  
11 (84.6%) 13 (9.6)    Primary 
4 (36.4%)
  
7 (63.6%)
  
11 (8.1)    Intermediate 
10 (28.6%) 25 (71.4%) 35 (25.7)    Secondary 
10 (29.4%) 24 (70.6%) 34 (25.0)    University                 
4 (44.4%)
  
5 (55.6%)
  
9 (6.6)    Higher degrees 
0.368 4.290    Monthly Income* 
8 (18.6%) 35 (81.4%) 43 (31.6)    > 3000  
11 (28.9%) 27 (71.1%) 38 (27.9)    3000-8000  
12 (36.4%) 21 (63.6%) 33(24.3)    9000-15000 
3 (37.5%) 5 (62.5%)
  
8 (5.9)    16000-25000 
2 (50.0%)
  
2 (50.0%)
  
4 (2.9)    >25000 
  10 (7.4)    No answer 
*Income calculated by Saudi Riyals. 
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Table 2: Disease characteristics 
Number of patients ()%  Variables 
 Chronic disease 
65 (47.8)    Yes 
69 (50.7)    No 
2 (1.5)    No answer 
  
 Type of cancer 
32 (23.5)    Colon 
46 (33.8)    Breast 
7 (5.1)    Leukemia 
6 (4.4)    Lymphoma 
6 (4.4)    Gynecological 
3 (2.2)    Prostate 
27 (19.9)    Other 
9 (6.6)    No answer 
  
 Stage  
16 (11.8)    Stage 1 
14 (10.3)    Stage 2 
21 (15.4)    Stage 3 
12 (8.8)    Stage 4 
70 (51.5)    Do not know 
3 (2.2)    No answer 
  
 Time since diagnosis 
12 (8.8)    > 3 months 
36 (26.5)    3-6 months 
45 (33.1)    7month - 1 year 
17 (12.5)    2-3 years 
23 (16.9)    >3 years 
3 (2.2)    No answer 
  
 Treatment 
122 (93.1)    Chemotherapy 
46 (35.1)    Surgery 
29 (22.1)    Radiotherapy 
12 (9.2)    Other 
3 (2.3)    No treatment 
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Table 3: Types of CAM therapies and frequency 
 
Type Percentage Frequency % 
Daily Weekly Occasionally Rarely 
Ruqya 75.0% 56.9 9.7 27.8 5.6 
Zamzam water 89.7% 50.6 9.2 34.5 5.7 
Honey 82.5% 57.5 3.8 30 8.8 
Black seed 54.6% 50.9 5.7 34 9.4 
Herbs 19.6% 40 13.3 26.7 20 
Vitamins 7.2% 50 0 16.7 33.3 
Olive oil 62.9% 50.8 8.2 31.1 9.8 
Dates 49.5% 60.4 4.2 29.2 6.3 
Cinnamon 10.3% 20 0 50 30 
Camel milk 17.7% 11.8 0 41.2 47.1 
Camel urine 15.6% 13.3 0  60 
Hijama 8.2% 0 0 12.5 87.5 
Cauterization 1.0% 0 0 100 0 
Other 18.8%     
 
(Figure 1) Patients’ sources of information about CAM 
 
 
 
 
